Venous thromboembolism encompasses deep venous thrombosis andpulmonary embolism, which represent different manifestationsof the same disease process. Indeed, most patients in whom symptomsof either condition develop will simultaneously have overt orsubclinical evidence of the other. Our understanding of thecauses and natural history of venous thromboembolism has undergoneconsiderable evolution in recent years, influencing the clinicalapproach to diagnosis and treatment. It is now recognized thatvenous thromboembolism is a chronic disease. Almost one thirdof patients have a recurrence within eight years after the initialevent.1 Furthermore, venous thromboembolism is at least in parta systemic . . . [Full Text of this Article]
Source Information
From the University of Pennsylvania School of Medicine, Philadelphia.
This article was published at www.nejm.org on February 24, 2003.
This article has been cited by other articles:
Wysowski, D. K., Nourjah, P., Swartz, L.
(2007). Bleeding Complications With Warfarin Use: A Prevalent Adverse Effect Resulting in Regulatory Action. Arch Intern Med
167: 1414-1419
[Abstract][Full Text]
Stief, T. W.
(2006). In vitro Simulation of Therapeutic Thrombolysis With Microtiter Plate Clot-Lysis Assay. CLIN APPL THROMB HEMOST
12: 21-32
[Abstract]
Kumana, C. R., Cheung, B. M. Y., Lauder, I. J.
(2003). The Burden of Rate Control in Atrial Fibrillation. J CARDIOVASC PHARMACOL THER
8: 247-248
Meroni, P L, Moia, M, Derksen, R H., Tincani, A, McIntyre, J A, Arnout, J M., Koike, T, Piette, J-C, Khamashta, M A, Shoenfeld, Y
(2003). Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis. Lupus
12: 504-507
[Abstract]
(2003). Low-Intensity Warfarin Reduces Risk for Recurrent Idiopathic DVT or PE. Journal Watch Dermatology
2003: 9-9
[Full Text]
(2003). Low-Intensity Warfarin Reduces Risk for Recurrent Idiopathic DVT or PE. JWatch Gastroenterology
2003: 10-10
[Full Text]
Previous
